This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?
Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year.
Sometimes stocks fall because something bad happens within a business. But stocks can fall for no reason at all during bear markets.
Don't let Wall Street's volatility get you down. Here are three reasons to consider InMode as a long-term growth stock for your portfolio.
Source Fool.com
